特利加压素

Terlipressin is a vasopressin analogue that's used to treat variceal bleeding in patients with portal hypertension.
特利加压素是一种血管加压素类似物，用于治疗门静脉高压症患者的食管胃底静脉曲张出血。
In the treatment of hepatorenal syndrome, terlipressin has shown significant improvement in renal function.
在治疗肝肾综合征时，特利加压素已显示出对肾功能显著改善的效果。
The administration of terlipressin can constrict blood vessels, thereby reducing portal pressure.
使用特利加压素可以收缩血管，从而降低门静脉压力。
A recent study compared the efficacy and safety of terlipressin versus octreotide for acute variceal bleeding.
最近的一项研究比较了在急性食管静脉曲张出血中，特利加压素与奥曲肽的有效性和安全性。
Terlipressin is usually administered intravenously as a bolus or continuous infusion.
特利加压素通常以静脉注射的方式给药，可以采用单次推注或连续输注。
The drug terlipressin is contraindicated in patients with known hypersensitivity to its components.
如果患者对药物成分已知过敏，则禁忌使用特利加压素。
Terlipressin therapy should be closely monitored due to the potential risk of ischemic complications.
应密切监测特利加压素疗法，因为它有可能导致缺血性并发症的风险。
Dosage adjustments may be necessary when using terlipressin concurrently with other drugs affecting the cardiovascular system.
当特利加压素与其他影响心血管系统的药物同时使用时，可能需要调整剂量。
Terlipressin has been found to be effective in controlling refractory hypotension in certain critical care settings.
发现特利加压素在某些重症监护环境下对于控制顽固性低血压有效。
Although terlipressin is well-tolerated by most patients, adverse effects like abdominal pain and diarrhea have been reported occasionally.
尽管大多数患者都能很好地耐受特利加压素，但偶尔会有腹痛和腹泻等不良反应报告。